![]() |
|
|
Department of Biochemistry, Memorial University of Newfoundland, St. Johns, Newfoundland, Canada
The liver is the major site of gluconeogenesis, the major organ of
amino acid catabolism and the only organ with a complete urea cycle.
These metabolic capabilities are related, and these relationships are
best exemplified by an examination of the disposal of the daily protein
load. Adults, ingesting a typical Western diet, will consume ~100 g
protein/d; the great bulk of this is metabolized by the liver. Although
textbooks suggest that these amino acids are oxidized in the liver,
total oxidation cannot occur within the confines of hepatic oxygen
uptake and ATP homeostasis. Rather, most amino acids are oxidized only
partially in the liver, with the bulk of their carbon skeleton being
converted to glucose. The nitrogen is converted to urea and, to a
lesser extent, to glutamine. The integration of the urea cycle with
gluconeogenesis ensures that the bulk of the reducing power (NADH)
required in the cytosol for gluconeogenesis can be provided by
ancillary reactions of the urea cycle. Glutamate is at the center of
these metabolic events for three reasons. First, through the
well-described transdeamination system involving aminotransferases
and glutamate dehydrogenase, glutamate plays a key catalytic role in
the removal of
-amino nitrogen from amino acids. Second, the
"glutamate family" of amino acids (arginine, ornithine, proline,
histidine and glutamine) require the conversion of these amino acids to
glutamate for their metabolic disposal. Third, glutamate serves as
substrate for the synthesis of N-acetylglutamate, an
essential allosteric activator of carbamyl phosphate synthetase I, a
key regulatory enzyme in the urea cycle.
KEY WORDS: gluconeogenesis urea synthesis liver metabolism dietary protein glutamate glutamine
This article has been cited by other articles:
![]() |
I. Nissim, O. Horyn, Y. Daikhin, I. Nissim, A. Lazarow, and M. Yudkoff Regulation of urea synthesis by agmatine in the perfused liver: studies with 15N Am J Physiol Endocrinol Metab, December 1, 2002; 283(6): E1123 - E1134. [Abstract] [Full Text] [PDF] |
||||